{
  "title": "AI for science in the 2024 report",
  "report_year": 2024,
  "period": "Historical snapshot: October 2024. Dates and populations are specified per row.",
  "methodology": "Sequence similarity is not biological efficacy. Cell-based experiments establish function under the tested conditions; they do not establish clinical safety or therapeutic effectiveness. AlphaFold 3 claims retain the access and baseline limitations noted in the original report.",
  "source_deck": "https://docs.google.com/presentation/d/1GmZmoWOa2O92BPrncRcTKa15xvQGhq7g4I4hJSNlC0M/edit",
  "web_edition_date": "2026-10-10",
  "rows": [
    {
      "measure": "CRISPR-Cas Atlas",
      "value": "More than 1M operons",
      "definition": "Diverse CRISPR-Cas systems mined for the dataset described in the report.",
      "printed_slide": 50,
      "pdf_page": 51,
      "source_url": "https://www.stateof.ai/State-of-AI-Report-2024.pdf#page=51"
    },
    {
      "measure": "Source genomic data",
      "value": "26.2 terabases",
      "definition": "Assembled microbial genome and metagenome data used to mine the atlas.",
      "printed_slide": 50,
      "pdf_page": 51,
      "source_url": "https://www.stateof.ai/State-of-AI-Report-2024.pdf#page=51"
    },
    {
      "measure": "OpenCRISPR-1 sequence similarity",
      "value": "71.7% to SpCas9",
      "definition": "Similarity reported for the selected functional editor, not an editing success rate.",
      "printed_slide": 50,
      "pdf_page": 51,
      "source_url": "https://www.stateof.ai/State-of-AI-Report-2024.pdf#page=51"
    }
  ]
}